Cytoplasmic signaling in the control of mitochondrial uproar?

Cell Communication and Signaling

Volumn 6, Issue , 2008, Pages

  Hermann, Martin ^a   Kuznetsov, Andrey ^a   Maglione, Manuel ^a   Smigelskaite, Julija ^a   Margreiter, Raimund ^a   Troppmair, Jakob ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67149098133     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-6-4     Document Type: Review

References (92)

1. Hibernation during hypoxia in cardiomyocytes. Role of mitochondria as the O2 sensor. GR Budinger, J Duranteau, NS Chandel, PT Schumacker, J Biol Chem 1998 273 6 3320 3326 10.1074/jbc.273.6.3320 9452449 (Pubitemid 28109746)
2. Unifying theory of hypoxia tolerance: molecular/metabolic defense and rescue mechanisms for surviving oxygen lack. PW Hochachka, LT Buck, CJ Doll, SC Land, Proc Natl Acad Sci U S A 1996 93 18 9493 9498 8790358 10.1073/pnas.93.18. 9493 (Pubitemid 26296636)
3. Ischemic preconditioning: from molecular mechanisms to therapeutic opportunities. H Otani, Antioxid Redox Signal 2008 10 2 207 247 10.1089/ars.2007.1679 17999631
4. Regulating cell survival by controlling cellular energy production: novel functions for ancient signaling pathways? AV Kuznetsov, M Janakiraman, R Margreiter, J Troppmair, FEBS Lett 2004 577 1-2 1 4 10.1016/j.febslet.2004.10. 021 15527752 (Pubitemid 39452352)
5. The internal structure of mitochondria. TG Frey, CA Mannella, Trends Biochem Sci 2000 25 7 319 324 10.1016/S0968-0004(00)01609-1 10871882 (Pubitemid 30421097)
6. Functions and dysfunctions of mitochondrial dynamics. SA Detmer, DC Chan, Nat Rev Mol Cell Biol 2007 8 11 870 879 10.1038/nrm2275 17928812 (Pubitemid 47622562)
7. The axonal transport of mitochondria. PJ Hollenbeck, WM Saxton, J Cell Sci 2005 118 Pt 23 5411 5419 16306220 10.1242/jcs.02745 (Pubitemid 43079283)
8. Live cell imaging of mitochondrial movement along actin cables in budding yeast. KL Fehrenbacher, HC Yang, AC Gay, TM Huckaba, LA Pon, Curr Biol 2004 14 22 1996 2004 10.1016/j.cub.2004.11.004 15556861 (Pubitemid 39547954)
9. Actin-dependent mitochondrial motility in mitotic yeast and cell-free systems: identification of a motor activity on the mitochondrial surface. VR Simon, TC Swayne, LA Pon, J Cell Biol 1995 130 2 345 354 7615636 10.1083/jcb.130.2.345
10. Dynamic mitochondria. MP Yaffe, Nat Cell Biol 1999 1 6 149 50 10.1038/14101 10559975
11. The machinery of mitochondrial inheritance and behavior. MP Yaffe, Science 1999 283 5407 1493 1497 10.1126/science.283.5407.1493 10066164 (Pubitemid 29133352)
12. Axonal mitochondrial transport and potential are correlated. KE Miller, MP Sheetz, J Cell Sci 2004 117 Pt 13 2791 2804 10.1242/jcs.01130 15150321 (Pubitemid 38997261)
13. Developmentally regulated mitochondrial fusion mediated by a conserved, novel, predicted GTPase. KG Hales, MT Fuller, Cell 1997 90 1 121 129 10.1016/S0092-8674(00)80319-0 9230308 (Pubitemid 28009424)
14. Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo. M Rojo, F Legros, D Chateau, A Lombes, J Cell Sci 2002 115 Pt 8 1663 1674 11950885 (Pubitemid 34520596)
15. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. H Chen, SA Detmer, AJ Ewald, EE Griffin, SE Fraser, DC Chan, JCell Biol 2003 160 2 189 200 10.1083/jcb.200211046 12527753 (Pubitemid 36254953)
16. The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. S Pich, D Bach, P Briones, M Liesa, M Camps, X Testar, M Palacin, A Zorzano, Hum Mol Genet 2005 14 11 1405 1415 10.1093/hmg/ddi149 15829499 (Pubitemid 40823451)
17. Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. E Smirnova, L Griparic, DL Shurland, AM van der Bliek, Mol Biol Cell 2001 12 8 2245 2256 11514614 (Pubitemid 33051954)
18. MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology. N Nakamura, Y Kimura, M Tokuda, S Honda, S Hirose, EMBO Rep 2006 7 10 1019 1022 16936636 10.1038/sj.embor.7400790 (Pubitemid 44480517)
19. Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death. S Wasiak, R Zunino, HM McBride, JCell Biol 2007 177 3 439 450 10.1083/jcb.200610042 17470634 (Pubitemid 46718273)
20. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. C Alexander, M Votruba, UE Pesch, DL Thiselton, S Mayer, A Moore, M Rodriguez, U Kellner, B Leo-Kottler, G Auburger, SS Bhattacharya, B Wissinger, Nat Genet 2000 26 2 211 215 10.1038/79944 11017080
21. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. S Zuchner, IV Mersiyanova, M Muglia, N Bissar-Tadmouri, J Rochelle, EL Dadali, M Zappia, E Nelis, A Patitucci, J Senderek, Y Parman, O Evgrafov, PD Jonghe, Y Takahashi, S Tsuji, MA Pericak-Vance, A Quattrone, E Battaloglu, AV Polyakov, V Timmerman, JM Schroder, JM Vance, Nat Genet 2004 36 5 449 451 10.1038/ng1341 15064763 (Pubitemid 38620027)
22. Mitochondria and cellular oxygen sensing in the HIF pathway. CT Taylor, BiochemJ 2008 409 1 19 26 10.1042/BJ20071249 18062771
23. Mitochondrial evolution. MW Gray, G Burger, BF Lang, Science 1999 283 5407 1476 1481 10.1126/science.283.5407.1476 10066161 (Pubitemid 29133349)
24. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. RD Guzy, PT Schumacker, Exp Physiol 2006 91 5 807 819 10.1113/expphysiol.2006.033506 16857720 (Pubitemid 44266577)
25. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. RD Guzy, B Hoyos, E Robin, H Chen, L Liu, KD Mansfield, MC Simon, U Hammerling, PT Schumacker, Cell Metab 2005 1 6 401 408 10.1016/j.cmet.2005.05.001 16054089 (Pubitemid 43960623)
26. Characterization of superoxide-producing sites in isolated brain mitochondria. AP Kudin, NY Bimpong-Buta, S Vielhaber, CE Elger, WS Kunz, J Biol Chem 2004 279 6 4127 4135 10.1074/jbc.M310341200 14625276 (Pubitemid 38198997)
27. Inhibitors of the quinone-binding site allow rapid superoxide production from mitochondrial NADH:ubiquinone oxidoreductase (complex I). AJ Lambert, MD Brand, J Biol Chem 2004 279 38 39414 39420 10.1074/jbc.M406576200 15262965 (Pubitemid 39258206)
28. Generation of reactive oxygen species by the mitochondrial electron transport chain. Y Liu, G Fiskum, D Schubert, J Neurochem 2002 80 5 780 787 10.1046/j.0022-3042.2002.00744.x 11948241 (Pubitemid 34809230)
29. Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. GL Semenza, Biochem J 2007 405 1 1 9 17555402 (Pubitemid 46999919)
30. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. S Jager, C Handschin, J St-Pierre, BM Spiegelman, Proc Natl Acad Sci U S A 2007 104 29 12017 12022 17609368 10.1073/pnas. 0705070104 (Pubitemid 47185622)
31. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. H Zong, JM Ren, LH Young, M Pypaert, J Mu, MJ Birnbaum, GI Shulman, Proc Natl Acad Sci U S A 2002 99 25 15983 15987 12444247 10.1073/pnas.252625599 (Pubitemid 35462735)
32. Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. R Bergeron, JM Ren, KS Cadman, IK Moore, P Perret, M Pypaert, LH Young, CF Semenkovich, GI Shulman, Am J Physiol Endocrinol Metab 2001 281 6 1340 6 11701451
33. Mitochondrial diseases in man and mouse. DC Wallace, Science 1999 283 5407 1482 1488 10.1126/science.283.5407.1482 10066162 (Pubitemid 29133350)
34. AMP-activated protein kinase - development of the energy sensor concept. DG Hardie, SA Hawley, JW Scott, J Physiol 2006 574 Pt 1 7 15 16644800 10.1113/jphysiol.2006.108944 (Pubitemid 43905792)
35. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. A Woods, K Dickerson, R Heath, SP Hong, M Momcilovic, SR Johnstone, M Carlson, D Carling, Cell Metab 2005 2 1 21 33 10.1016/j.cmet.2005.06.005 16054096 (Pubitemid 43239822)
36. Identification of phosphorylation sites in AMP-activated protein kinase (AMPK) for upstream AMPK kinases and study of their roles by site-directed mutagenesis. A Woods, D Vertommen, D Neumann, R Turk, J Bayliss, U Schlattner, T Wallimann, D Carling, MH Rider, J Biol Chem 2003 278 31 28434 28442 10.1074/jbc.M303946200 12764152 (Pubitemid 36935745)
37. The AMP-activated protein kinase cascade - a unifying system for energy control. D Carling, Trends Biochem Sci 2004 29 1 18 24 10.1016/j.tibs.2003.11. 005 14729328 (Pubitemid 38068476)
38. AMPK: a key sensor of fuel and energy status in skeletal muscle. DG Hardie, K Sakamoto, Physiology (Bethesda) 2006 21 48 60 16443822 (Pubitemid 43752517)
39. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. AS Marsin, L Bertrand, MH Rider, J Deprez, C Beauloye, MF Vincent, G Van den Berghe, D Carling, L Hue, Curr Biol 2000 10 20 1247 1255 10.1016/S0960-9822(00)00742-9 11069105
40. Activation of 5'-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells. Role of peroxynitrite. MH Zou, XY Hou, CM Shi, S Kirkpatick, F Liu, MH Goldman, RA Cohen, J Biol Chem 2003 278 36 34003 34010 10.1074/jbc.M300215200 12824177 (Pubitemid 37553236)
41. The AMP-activated protein kinase: more than an energy sensor. L Hue, MH Rider, Essays Biochem 2007 43 121 137 10.1042/BSE0430121 17705797
42. Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. S Horman, G Browne, U Krause, J Patel, D Vertommen, L Bertrand, A Lavoinne, L Hue, C Proud, M Rider, Curr Biol 2002 12 16 1419 1423 10.1016/S0960-9822(02)01077-1 12194824 (Pubitemid 34915545)
43. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. DR Bolster, SJ Crozier, SR Kimball, LS Jefferson, J Biol Chem 2002 277 27 23977 23980 10.1074/jbc.C200171200 11997383 (Pubitemid 34951907)
44. A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway. N Kimura, C Tokunaga, S Dalal, C Richardson, K Yoshino, K Hara, BE Kemp, LA Witters, O Mimura, K Yonezawa, Genes Cells 2003 8 1 65 79 10.1046/j.1365-2443.2003.00615.x 12558800 (Pubitemid 36511694)
45. TSC2 mediates cellular energy response to control cell growth and survival. K Inoki, T Zhu, KL Guan, Cell 2003 115 5 577 590 10.1016/S0092- 8674(03)00929-2 14651849 (Pubitemid 37506046)
46. AMPK phosphorylation of raptor mediates a metabolic checkpoint. DM Gwinn, DB Shackelford, DF Egan, MM Mihaylova, A Mery, DS Vasquez, BE Turk, RJ Shaw, Mol Cell 2008 30 2 214 226 10.1016/j.molcel.2008.03.003 18439900 (Pubitemid 351626684)
47. 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. EJ Kurth-Kraczek, MF Hirshman, LJ Goodyear, WW Winder, Diabetes 1999 48 8 1667 1671 10.2337/diabetes.48.8.1667 10426389 (Pubitemid 29356879)
48. AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. JT Treebak, S Glund, A Deshmukh, DK Klein, YC Long, TE Jensen, SB Jorgensen, B Viollet, L Andersson, D Neumann, T Wallimann, EA Richter, AV Chibalin, JR Zierath, JF Wojtaszewski, Diabetes 2006 55 7 2051 2058 10.2337/db06-0175 16804075 (Pubitemid 44509979)
49. Chronic activation of 5'-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. BF Holmes, EJ Kurth-Kraczek, WW Winder, J Appl Physiol 1999 87 5 1990 1995 10562646
50. Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase. D Zheng, PS MacLean, SC Pohnert, JB Knight, AL Olson, WW Winder, GL Dohm, J Appl Physiol 2001 91 3 1073 1083 11509501 (Pubitemid 32803899)
51. Molecular system bioenergetics: regulation of substrate supply in response to heart energy demands. V Saks, R Favier, R Guzun, U Schlattner, T Wallimann, J Physiol 2006 577 Pt 3 769 777 17008367 10.1113/jphysiol.2006.120584 (Pubitemid 44873644)
52. Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism. T Hayashi, MF Hirshman, N Fujii, SA Habinowski, LA Witters, LJ Goodyear, Diabetes 2000 49 4 527 531 10.2337/diabetes.49.4.527 10871188 (Pubitemid 30183739)
53. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. R Bergeron, SF Previs, GW Cline, P Perret, RR Russell 3rd, LH Young, GI Shulman, Diabetes 2001 50 5 1076 1082 10.2337/diabetes.50.5.1076 11334411 (Pubitemid 32374538)
54. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. RR Russell 3rd, R Bergeron, GI Shulman, LH Young, Am J Physiol 1999 277 2 Pt 2 643 9 10444490
55. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Z Wu, P Puigserver, U Andersson, C Zhang, G Adelmant, V Mootha, A Troy, S Cinti, B Lowell, RC Scarpulla, BM Spiegelman, Cell 1999 98 1 115 124 10.1016/S0092-8674(00)80611-X 10412986 (Pubitemid 29331201)
56. Increased oxygen radical formation and mitochondrial dysfunction mediate beta cell apoptosis under conditions of AMP-activated protein kinase stimulation. Y Cai, GA Martens, SA Hinke, H Heimberg, D Pipeleers, M Van de Casteele, Free Radic Biol Med 2007 42 1 64 78 10.1016/j.freeradbiomed.2006.09. 018 17157194 (Pubitemid 44839152)
57. Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. MH Zou, SS Kirkpatrick, BJ Davis, JS Nelson, WG Wiles, U Schlattner, D Neumann, M Brownlee, MB Freeman, MH Goldman, J Biol Chem 2004 279 42 43940 43951 10.1074/jbc.M404421200 15265871 (Pubitemid 39390702)
58. Oncogenic alterations of metabolism. CV Dang, GL Semenza, Trends Biochem Sci 1999 24 2 68 72 10.1016/S0968-0004(98)01344-9 10098401 (Pubitemid 29346576)
59. Tumor cell metabolism: cancer's Achilles' heel. G Kroemer, J Pouyssegur, Cancer Cell 2008 13 6 472 482 10.1016/j.ccr.2008.05.005 18538731 (Pubitemid 351766797)
60. Functional imaging of mitochondria in saponin-permeabilized mice muscle fibers. AV Kuznetsov, O Mayboroda, D Kunz, K Winkler, W Schubert, WS Kunz, J Cell Biol 1998 140 5 1091 1099 9490722 10.1083/jcb.140.5.1091 (Pubitemid 28128869)
61. Mitochondrial tumour suppressors: a genetic and biochemical update. E Gottlieb, IP Tomlinson, Nat Rev Cancer 2005 5 11 857 866 10.1038/nrc1737 16327764 (Pubitemid 41746030)
62. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. A King, MA Selak, E Gottlieb, Oncogene 2006 25 34 4675 4682 10.1038/sj.onc.1209594 16892081 (Pubitemid 44187617)
63. Mitochondrial mutations in cancer. M Brandon, P Baldi, DC Wallace, Oncogene 2006 25 34 4647 4662 10.1038/sj.onc.1209607 16892079 (Pubitemid 44187615)
64. Delayed graft function in kidney transplantation. N Perico, D Cattaneo, MH Sayegh, G Remuzzi, Lancet 2004 364 9447 1814 1827 10.1016/S0140-6736(04) 17406-0 15541456 (Pubitemid 39488068)
65. Delayed graft function: risk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation. AJ McLaren, W Jassem, DW Gray, SV Fuggle, KI Welsh, PJ Morris, Clin Transplant 1999 13 3 266 272 10.1034/j.1399-0012.1999.130308.x 10383108 (Pubitemid 29255784)
66. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. M Deschênes, SH Belle, RA Krom, RK Zetterman, JR Lake, Transplantation 1998 66 3 302 310 10.1097/00007890- 199808150-00005 9721797
67. Targeting antioxidants to mitochondria: a potential new therapeutic strategy for cardiovascular diseases. VM Victor, M Rocha, Curr Pharm Des 2007 13 8 845 863 10.2174/138161207780363077 17430185 (Pubitemid 46585507)
68. Mitochondrial targets of oxidative stress during renal ischemia/reperfusion. DL Cruthirds, L Novak, KM Akhi, PW Sanders, JA Thompson, LA MacMillan-Crow, Arch Biochem Biophys 2003 412 1 27 33 10.1016/S0003-9861(03) 00039-0 12646264 (Pubitemid 36324361)
69. Tetrahydrobiopterin attenuates microvascular reperfusion injury following murine pancreas transplantation. M Maglione, M Hermann, P Hengster, S Schneeberger, W Mark, P Obrist, G Werner-Felmayer, ER Werner, R Margreiter, G Brandacher, Am J Transplant 2006 6 7 1551 1559 10.1111/j.1600-6143.2006.01345.x 16827855 (Pubitemid 43945795)
70. Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. Q Chen, S Moghaddas, CL Hoppel, EJ Lesnefsky, Am J Physiol Cell Physiol 2008 294 2 460 6 10.1152/ajpcell.00211.2007 18077608 (Pubitemid 351276913)
71. The role of mitochondria in ischemia/reperfusion injury. W Jassem, SV Fuggle, M Rela, DD Koo, ND Heaton, Transplantation 2002 73 4 493 499 10.1097/00007890-200202270-00001 11889418 (Pubitemid 34193605)
72. Targeting antioxidants to mitochondria and cardiovascular diseases: the effects of mitoquinone. M Milagros Rocha, VM Victor, Med Sci Monit 2007 13 7 A132 45 17599037
73. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. PS Brookes, Y Yoon, JL Robotham, MW Anders, SS Sheu, Am J Physiol Cell Physiol 2004 287 4 817 33 10.1152/ajpcell.00139.2004 15355853 (Pubitemid 39238305)
74. Mitochondria: a target for neuroprotective interventions in cerebral ischemia-reperfusion. M Christophe, S Nicolas, Curr Pharm Des 2006 12 6 739 757 10.2174/138161206775474242 16472163
75. Breaking the mitochondrial barrier. JC Martinou, DR Green, Nat Rev Mol Cell Biol 2001 2 1 63 67 10.1038/35048069 11413467 (Pubitemid 33676963)
76. Mitochondria, the killer organelles and their weapons. L Ravagnan, T Roumier, G Kroemer, J Cell Physiol 2002 192 2 131 137 10.1002/jcp.10111 12115719 (Pubitemid 34747781)
77. Raf and the road to cell survival: a tale of bad spells, ring bearers and detours. J Troppmair, UR Rapp, Biochem Pharmacol 2003 66 8 1341 1345 10.1016/S0006-2952(03)00483-0 14555207 (Pubitemid 38373320)
78. Regulation of mitochondrial oxidative phosphorylation through cell signaling. M Huttemann, I Lee, L Samavati, H Yu, JW Doan, Biochim Biophys Acta 2007 1773 12 1701 1720 10.1016/j.bbamcr.2007.10.001 18240421 (Pubitemid 350191980)
79. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? JE Chipuk, DR Green, Trends Cell Biol 2008 18 4 157 164 10.1016/j.tcb.2008.01.007 18314333
80. Lucifer's labyrinth - ten years of path finding in cell death. P Meier, KH Vousden, Mol Cell 2007 28 5 746 754 10.1016/j.molcel.2007.11.016 18082600 (Pubitemid 350225737)
81. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. U Maurer, C Charvet, AS Wagman, E Dejardin, DR Green, Mol Cell 2006 21 6 749 760 10.1016/j.molcel.2006.02.009 16543145 (Pubitemid 43376126)
82. Survival signaling by C-RAF: mitochondrial reactive oxygen species and Ca2+ are critical targets. AV Kuznetsov, J Smigelskaite, C Doblander, M Janakiraman, M Hermann, M Wurm, SF Scheidl, R Sucher, A Deutschmann, J Troppmair, Mol Cell Biol 2008 28 7 2304 2313 18212057 10.1128/MCB.00683-07 (Pubitemid 351429976)
83. cAMP controls oxygen metabolism in mammalian cells. C Piccoli, S Scacco, F Bellomo, A Signorile, A Iuso, D Boffoli, R Scrima, N Capitanio, S Papa, FEBS Lett 2006 580 18 4539 4543 10.1016/j.febslet.2006.06.085 16870178 (Pubitemid 44118245)
84. Mammalian complex I: A regulable and vulnerable pacemaker in mitochondrial respiratory function. S Papa, D De Rasmo, S Scacco, A Signorile, Z Technikova-Dobrova, G Palmisano, AM Sardanelli, F Papa, D Panelli, R Scaringi, A Santeramo, Biochim Biophys Acta 2008 18455500
85. Alterations in oxidative phosphorylation complex proteins in the hearts of transgenic mice that overexpress the p38 MAP kinase activator, MAP kinase kinase 6. JA Wall, J Wei, M Ly, P Belmont, JJ Martindale, D Tran, J Sun, WJ Chen, W Yu, P Oeller, S Briggs, AB Gustafsson, MR Sayen, RA Gottlieb, CC Glembotski, Am J Physiol Heart Circ Physiol 2006 291 5 2462 72 10.1152/ajpheart.01311.2005 16766635
86. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. K Bensaad, A Tsuruta, MA Selak, MN Vidal, K Nakano, R Bartrons, E Gottlieb, KH Vousden, Cell 2006 126 1 107 120 10.1016/j.cell.2006.05.036 16839880 (Pubitemid 44040989)
87. Apoptosis and aging: role of p66Shc redox protein. E Migliaccio, M Giorgio, PG Pelicci, Antioxid Redox Signal 2006 8 3-4 600 608 10.1089/ars.2006.8.600 16677103 (Pubitemid 43741328)
88. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. M Giorgio, E Migliaccio, F Orsini, D Paolucci, M Moroni, C Contursi, G Pelliccia, L Luzi, S Minucci, M Marcaccio, P Pinton, R Rizzuto, P Bernardi, F Paolucci, PG Pelicci, Cell 2005 122 2 221 233 10.1016/j.cell.2005.05.011 16051147 (Pubitemid 41032986)
89. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. H Kamata, S Honda, S Maeda, L Chang, H Hirata, M Karin, Cell 2005 120 5 649 661 10.1016/j.cell.2004.12.041 15766528 (Pubitemid 40343077)
90. From death receptor to reactive oxygen species and c-Jun N-terminal protein kinase: the receptor-interacting protein 1 odyssey. V Temkin, M Karin, Immunol Rev 2007 220 8 21 10.1111/j.1600-065X.2007.00560.x 17979836 (Pubitemid 350045563)
91. Free radicals and antioxidants in normal physiological functions and human disease. M Valko, D Leibfritz, J Moncol, MT Cronin, M Mazur, J Telser, Int J Biochem Cell Biol 2007 39 1 44 84 10.1016/j.biocel.2006.07.001 16978905 (Pubitemid 44566469)
92. Cellular responses to reactive oxygen species-induced DNA damage and aging. C Bertram, R Hass, Biol Chem 2008 389 3 211 220 10.1515/BC.2008.031 18208352 (Pubitemid 351329029)